Cell line · CVCL_GR23
EO771
Cancer cell line, Mus musculus. Malignant neoplasms of the mouse mammary gland. 87 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. EO771. Cell lines, record CVCL_GR23. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_GR23
On this page
Cell line
As Cellosaurus gives it.
- Name
- EO771
- Accession
- CVCL_GR23
- RRID
- RRID:CVCL_GR23
- Synonyms
- Eo771, E0771, EO 771
- Species
- Mus musculus (Mouse)
- Sex
- Female
- Age at sampling
- Age unspecified
- Category
- Cancer cell line
- Diseases
- Malignant neoplasms of the mouse mammary gland (NCIt C21678)
- Derived from
- Mammary gland (in situ)
- Entry created
- 2016-09-26
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers87
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| RAMP3 is associated with macrophage-driven immune exclusion and promotes resistance to PD-1 blockade in breast cancer: integrated in vivo and single-cell transcriptomic analyses. | J Transl Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Mitochondrial transfer between breast cancer cells promotes ROS-dependent proliferation. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Reprogramming tumor cells with LCOR mRNA nanotherapy to enhance immunotherapy. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Compartment-specific PPARδ activity controls the outcome of cancer-immune cell competition and immunotherapy efficacy. | Nat Immunol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment. | J Exp Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cancer-Intrinsic Protein Neddylation Modulates the Intratumoral Immune Landscape to Constrain Immune Checkpoint Blockade Therapy. | Cancer Immunol Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Tumor-Associated Platelets Suppress T-cell Function and Promote Immune Evasion in TNBC via the P-selectin/P-selectin Glycoprotein Ligand 1 Pathway. | Cancer Res Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Pharmacologic Modulation of ARID3A with Rimegepant Reactivates Type I Interferon Signaling and Sensitizes Triple-Negative Breast Cancer to PD-1 Blockade. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ICAM1high Neutrophils Sculpt Tumor Evolution and Metastasis Through Symbiotic Adhesion and Reverse Migration. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Linking tumor viability and immune infiltration with dual-nucleus MRI in preclinical models. | Npj Imaging | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 87
See all 87 papersRelatives8
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EO-NY | CVCL_A2HI | Cell lines | |
| Derived from it | EO771-Luc | CVCL_C9CA | Cell lines | |
| Derived from it | EO771.lmb | CVCL_B0A2 | Cell lines | |
| Derived from it | EO771E2 | CVCL_VE17 | Cell lines | |
| Derived from it | Ubigene EO771 Ccl5 KO | CVCL_D8G0 | Cell lines | |
| Derived from it | Ubigene EO771 Epha2 KO | CVCL_D8G1 | Cell lines | |
| Derived from it | Ubigene EO771 Fabp4 KO | CVCL_D8G2 | Cell lines | |
| Derived from it | Ubigene EO771 Pik3ca KO | CVCL_D8G3 | Cell lines |
Cell banks3
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_GR23
GET https://conductscience.org/api/cell-lines/v1/CVCL_GR23/papers?page=2